Advanced in Appendix Cancer

Helgi Birgisson

Akademiska Sjukhuset
Uppsala, C, SE 
Advanced in Appendix Cancer
Akademiska Sjukhuset
Uppsala, C, SE 
OverviewLocationsClinical Research

Overview

Helgi Birgisson practices in Uppsala, Sweden. Birgisson is rated as an Advanced expert by MediFind in the treatment of Appendix Cancer. Their top areas of expertise are Colorectal Cancer, Appendix Cancer, Pseudomyxoma Peritonei, Cerebral Hypoxia, and Mastectomy.

Their clinical research consists of co-authoring 68 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 5 articles in the study of Appendix Cancer.

Locations

Akademiska Sjukhuset
Uppsala, C 75185, Sweden
Other Locations
Vaesteras, U, Sweden

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Nordic Extended Abdominoperineal Excision (NEAPE) Study, a RCT Comparing a Porcine Acellular Dermal Collagen Implant (Biological Mesh) With a Gluteus Maximus Flap for Reconstruction of Pelvic Floor After ELAPE in Rectal Cancer
Nordic Extended Abdominoperineal Excision (NEAPE) Study, a RCT Comparing a Porcine Acellular Dermal Collagen Implant (Biological Mesh) With a Gluteus Maximus Flap for Reconstruction of Pelvic Floor After ELAPE in Rectal Cancer
Enrollment Status: Completed
Publish Date: October 03, 2025
Intervention Type: Procedure
Study Phase: Not Applicable

68 Total Publications

Thirty years of population-based breast cancer screening in Iceland: a comparison of quality indicators and tumour characteristics between women aged 40-49 and 50-69 years.
Thirty years of population-based breast cancer screening in Iceland: a comparison of quality indicators and tumour characteristics between women aged 40-49 and 50-69 years.
Journal: Acta oncologica (Stockholm, Sweden)
Published: June 10, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Birgisson's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile